Header Logo

Robert C Welliver

InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentDept of Pediatrics
AddressOUCPB 12112
1200 Childrens Ave
Oklahoma City OK 73104
Phone405/271-5703 ext 45678
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nguyen AL, Johnson PN, Neely SB, Hughes KM, Sekar KC, Welliver RC, Miller JL. Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease. J Pediatr Pharmacol Ther. 2021; 26(4):372-378. PMID: 34035682.
    2. Welliver RC, Papin JF, Preno A, Ivanov V, Tian JH, Lu H, Guebre-Xabier M, Flyer D, Massare MJ, Glenn G, Ellingsworth L, Smith G. Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge. Vaccine. 2020 01 29; 38(5):1258-1270. PMID: 31761502.
      Citations: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    3. Miller JL, Johnson PN, White BP, Neely SB, Chaaban H, Kassa N, Welliver RC. Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit. Pediatr Infect Dis J. 2019 06; 38(6):605-607. PMID: 30489466.
      Citations:    Fields:    Translation:HumansCells
    4. Anderson EJ, DeVincenzo JP, Simões EAF, Krilov LR, Forbes ML, Pannaraj PS, Espinosa CM, Welliver RC, Wolkoff LI, Yogev R, Checchia PA, Domachowske JB, Halasa N, McBride SJ, Kumar VR, McLaurin KK, Rizzo CP, Ambrose CS. SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis. Am J Perinatol. 2020 03; 37(4):421-429. PMID: 30991438.
      Citations: 10     Fields:    Translation:HumansCells
    5. Ivanov VA, Wolf RF, Papin JF, Anderson MP, Hill CL, Welliver RC. Apnea induction for invasive lung function testing in infant olive baboons: Comparison of intravenous propofol versus hyperventilation. J Med Primatol. 2018 02; 47(1):46-50. PMID: 29023804.
      Citations:    Fields:    Translation:Animals
    6. Hughes KM, Johnson PN, Anderson MP, Sekar KC, Welliver RC, Miller JL. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. J Pediatr Pharmacol Ther. 2017 Jan-Feb; 22(1):33-40. PMID: 28337079.
    7. Allen HC, Welliver RC, Fogarty MW, Gessouroun M, Henry ED. Intravenous Immunoglobulin Therapy for Cerebral Vasculitis Associated with Rocky Mountain Spotted Fever. J Pediatr Intensive Care. 2017 Jun; 6(2):142-144. PMID: 31073439.
    8. DeLeon SD, Welliver RC. Paenibacillus alvei Sepsis in a Neonate. Pediatr Infect Dis J. 2016 Mar; 35(3):358. PMID: 26866854.
      Citations: 4     Fields:    Translation:HumansCells
    9. Simões EA, Carbonell-Estrany X, Guilbert T, Mansbach JM, Piedra PA, Ramilo O, Welliver R. Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries. Pediatr Infect Dis J. 2015 Oct; 34(10):1086-92. PMID: 26121204.
      Citations: 6     Fields:    Translation:Humans
    10. Papin JF, Wolf RF, Kosanke SD, Jenkins JD, Moore SN, Anderson MP, Welliver RC. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol. 2013 Apr 15; 304(8):L530-9. PMID: 23418091.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    11. Awasthi S, Singh B, Welliver RC, Dietert RR. Lung dendritic cell developmental programming, environmental stimuli, and asthma in early periods of life. J Allergy (Cairo). 2012; 2012:176468. PMID: 23209481.
    12. Mlinaric-Galinovic G, Tabain I, Kukovec T, Vojnovic G, Bozikov J, Bogovic-Cepin J, Ivkovic-Jurekovic I, Knezovic I, Tesovic G, Welliver RC. Analysis of biennial outbreak pattern of respiratory syncytial virus according to subtype (A and B) in the Zagreb region. Pediatr Int. 2012 Jun; 54(3):331-5. PMID: 22212608.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    13. He Y, Abid A, Fisher R, Eller N, Mikolajczyk M, Welliver RC, Bonner AB, Scott DE, Reed JL. Mucosal antibody responses are directed by viral burden in children with acute influenza infection. Influenza Other Respir Viruses. 2013 Jan; 7(1):46-54. PMID: 22405508.
      Citations: 2     Fields:    Translation:HumansCells
    14. Checchia PA, Nalysnyk L, Fernandes AW, Mahadevia PJ, Xu Y, Fahrbach K, Welliver RC. Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis. Pediatr Crit Care Med. 2011 Sep; 12(5):580-8. PMID: 21200358.
      Citations: 16     Fields:    Translation:HumansCells
    15. D'Angio CT, Heyne RJ, Duara S, Holmes LC, O'Shea TM, Wang H, Wang D, Sánchez PJ, Welliver RC, Ryan RM, Schnabel KC, Hall CB. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr Infect Dis J. 2011 Jul; 30(7):570-4. PMID: 21273938.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    16. Ryan RM, Wilding GE, Wynn RJ, Welliver RC, Holm BA, Leach CL. Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unit. J Perinatol. 2011 Sep; 31(9):607-14. PMID: 21436785.
      Citations: 2     Fields:    Translation:Humans
    17. Welliver RC, Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin. 2010 Sep; 26(9):2175-81. PMID: 20666690.
      Citations: 38     Fields:    Translation:HumansCells
    18. Welliver RC. Pharmacotherapy of respiratory syncytial virus infection. Curr Opin Pharmacol. 2010 Jun; 10(3):289-93. PMID: 20493773.
      Citations: 14     Fields:    Translation:HumansAnimals
    19. Krilov LR, Weiner LB, Yogev R, Fergie J, Katz BZ, Henrickson KJ, Welliver RC. The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicine. Pediatrics. 2009 Dec; 124(6):1682-4. PMID: 19948634.
      Citations: 8     Fields:    Translation:Humans
    20. Gill MA, Welliver RC. Motavizumab for the prevention of respiratory syncytial virus infection in infants. Expert Opin Biol Ther. 2009 Oct; 9(10):1335-45. PMID: 19764889.
      Citations: 14     Fields:    Translation:Humans
    21. Mlinaric-Galinovic G, Vojnovic G, Cepin-Bogovic J, Bace A, Bozikov J, Welliver RC, Wahn U, Cebalo L. Does the viral subtype influence the biennial cycle of respiratory syncytial virus? Virol J. 2009 Sep 07; 6:133. PMID: 19735540.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    22. Welliver R. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Paediatr Respir Rev. 2009 Jun; 10 Suppl 1:6-8. PMID: 19651390.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    23. Reed JL, Welliver TP, Sims GP, McKinney L, Velozo L, Avendano L, Hintz K, Luma J, Coyle AJ, Welliver RC. Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection. J Infect Dis. 2009 Apr 15; 199(8):1128-38. PMID: 19278337.
      Citations: 32     Fields:    Translation:HumansCells
    24. Mlinaric-Galinovic G, Vilibic-Cavlek T, Ljubin-Sternak S, Drazenovic V, Galinovic I, Tomic V, Welliver RC. Eleven consecutive years of respiratory syncytial virus outbreaks in Croatia. Pediatr Int. 2009 Apr; 51(2):237-40. PMID: 19405923.
      Citations: 9     Fields:    Translation:Humans
    25. Reed JL, Brewah YA, Delaney T, Welliver T, Burwell T, Benjamin E, Kuta E, Kozhich A, McKinney L, Suzich J, Kiener PA, Avendano L, Velozo L, Humbles A, Welliver RC, Coyle AJ. Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis. J Infect Dis. 2008 Dec 15; 198(12):1783-93. PMID: 18980502.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    26. Welliver TP, Reed JL, Welliver RC. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J. 2008 Oct; 27(10 Suppl):S92-6. PMID: 18820587.
      Citations: 46     Fields:    Translation:HumansCells
    27. Welliver RC. The immune response to respiratory syncytial virus infection: friend or foe? Clin Rev Allergy Immunol. 2008 Apr; 34(2):163-73. PMID: 17985249.
      Citations: 18     Fields:    Translation:HumansCells
    28. Mlinaric-Galinovic G, Welliver RC, Vilibic-Cavlek T, Ljubin-Sternak S, Drazenovic V, Galinovic I, Tomic V. The biennial cycle of respiratory syncytial virus outbreaks in Croatia. Virol J. 2008 Jan 28; 5:18. PMID: 18226194.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    29. Ogra PL, Welliver RC. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. Nestle Nutr Workshop Ser Pediatr Program. 2008; 61:145-81. PMID: 18196951.
      Citations: 13     Fields:    Translation:HumansCells
    30. Welliver RC. Temperature, humidity, and ultraviolet B radiation predict community respiratory syncytial virus activity. Pediatr Infect Dis J. 2007 Nov; 26(11 Suppl):S29-35. PMID: 18090197.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    31. Elliott MB, Welliver RC, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, Souza V, Terio NB, Hancock GE. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol. 2007 Apr; 79(4):447-56. PMID: 17311330.
      Citations: 8     Fields:    Translation:HumansCells
    32. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007 Apr 15; 195(8):1126-36. PMID: 17357048.
      Citations: 193     Fields:    Translation:HumansCells
    33. Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murguía De Sierra T, Simoes EA, Shaha S, Welliver R. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007 Oct; 135(7):1077-90. PMID: 17346359.
      Citations: 67     Fields:    Translation:HumansCellsPHPublic Health
    34. Chávez-Bueno S, Mejías A, Welliver RC. Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis. Treat Respir Med. 2006; 5(6):483-94. PMID: 17154675.
      Citations: 1     Fields:    Translation:HumansCells
    35. Garofalo RP, Hintz KH, Hill V, Patti J, Ogra PL, Welliver RC. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol. 2005 Feb; 75(2):282-9. PMID: 15602730.
      Citations: 26     Fields:    Translation:Humans
    36. Garofalo RP, Hintz KH, Hill V, Ogra PL, Welliver RC. Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol. 2004 Jun; 73(2):289-94. PMID: 15122806.
      Citations: 15     Fields:    Translation:HumansCells
    37. Krishnan S, Halonen M, Welliver RC. Innate immune responses in respiratory syncytial virus infections. Viral Immunol. 2004; 17(2):220-33. PMID: 15279701.
      Citations: 19     Fields:    Translation:HumansCells
    38. Welliver RC. Respiratory syncytial virus infection: therapy and prevention. Paediatr Respir Rev. 2004; 5 Suppl A:S127-33. PMID: 14980257.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    39. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003 Nov; 143(5 Suppl):S112-7. PMID: 14615709.
      Citations: 113     Fields:    Translation:Humans
    40. Krishnan S, Craven M, Welliver RC, Ahmad N, Halonen M. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J Infect Dis. 2003 Aug 01; 188(3):433-9. PMID: 12870126.
      Citations: 18     Fields:    Translation:HumansCells
    41. Welliver RC, Hintz KH, Glori M, Welliver RC. Zileuton reduces respiratory illness and lung inflammation, during respiratory syncytial virus infection, in mice. J Infect Dis. 2003 Jun 01; 187(11):1773-9. PMID: 12751035.
      Citations: 9     Fields:    Translation:AnimalsCells
    42. Ohki S, Liu JZ, Schaller J, Welliver RC. The compound DATEM inhibits respiratory syncytial virus fusion activity with epithelial cells. Antiviral Res. 2003 Apr; 58(2):115-24. PMID: 12742571.
      Citations: 5     Fields:    Translation:HumansCells
    43. Welliver RC. Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S6-10; discussion S10-2. PMID: 12671447.
      Citations: 36     Fields:    Translation:HumansCells
    44. Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J. 2002 May; 21(5):457-61. PMID: 12150192.
      Citations: 24     Fields:    Translation:HumansCells
    45. Welliver RC, Ogra PL. RSV, IgE, and wheezing. J Pediatr. 2001 Dec; 139(6):903-5. PMID: 11743524.
      Citations: 1     Fields:    Translation:Humans
    46. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis. 2001 Aug 15; 184(4):393-9. PMID: 11471095.
      Citations: 83     Fields:    Translation:HumansCells
    47. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev. 2001 Apr; 14(2):430-45. PMID: 11292646.
      Citations: 118     Fields:    Translation:HumansCellsPHPublic Health
    48. van Schaik SM, Obot N, Enhorning G, Hintz K, Gross K, Hancock GE, Stack AM, Welliver RC. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med Virol. 2000 Oct; 62(2):257-66. PMID: 11002257.
      Citations: 43     Fields:    Translation:AnimalsCells
    49. van Schaik SM, Welliver RC, Kimpen JL. Novel pathways in the pathogenesis of respiratory syncytial virus disease. Pediatr Pulmonol. 2000 Aug; 30(2):131-8. PMID: 10922135.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    50. Welliver RC. Immunology of respiratory syncytial virus infection: eosinophils, cytokines, chemokines and asthma. Pediatr Infect Dis J. 2000 Aug; 19(8):780-3; discussion 784-5; 811-3. PMID: 10959758.
      Citations: 3     Fields:    Translation:Humans
    51. Ehlenfield DR, Cameron K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics. 2000 Jan; 105(1 Pt 1):79-83. PMID: 10617708.
      Citations: 28     Fields:    Translation:HumansCells
    52. Welliver RC. Immunologic mechanisms of virus-induced wheezing and asthma. J Pediatr. 1999 Aug; 135(2 Pt 2):14-20. PMID: 10431134.
      Citations: 8     Fields:    Translation:Humans
    53. Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA. Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease. Antimicrob Agents Chemother. 1999 May; 43(5):1183-8. PMID: 10223933.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    54. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC, Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol. 1999 Apr; 103(4):630-6. PMID: 10200012.
      Citations: 38     Fields:    Translation:HumansCells
    55. Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J. 1999 Mar; 18(3):223-31. PMID: 10093942.
      Citations: 18     Fields:    Translation:HumansCells
    56. Simoes EA, Sondheimer HM, Top FH, Meissner HC, Welliver RC, Kramer AA, Groothuis JR. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr. 1998 Oct; 133(4):492-9. PMID: 9787686.
      Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
    57. van Schaik SM, Enhorning G, Vargas I, Welliver RC. Respiratory syncytial virus affects pulmonary function in BALB/c mice. J Infect Dis. 1998 Feb; 177(2):269-76. PMID: 9466511.
      Citations: 36     Fields:    Translation:AnimalsCells
    58. Welliver RC. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection. Semin Perinatol. 1998 Feb; 22(1):87-95. PMID: 9523402.
      Citations: 3     Fields:    Translation:HumansCells
    59. Van Schaik SM, Vargas I, Welliver RC, Enhorning G. Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus. Pediatr Res. 1997 Aug; 42(2):169-73. PMID: 9262218.
      Citations: 7     Fields:    Translation:AnimalsCells
    60. Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61. PMID: 9041304.
      Citations: 31     Fields:    Translation:HumansCellsCTClinical Trials
    61. Meissner HC, Welliver RC, Chartrand SA, Fulton DR, Rodriguez WJ, Groothuis JR. Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin. Pediatr Infect Dis J. 1996 Dec; 15(12):1059-68. PMID: 8970212.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    62. Simoes EA, Groothuis JR, Tristram DA, Allessi K, Lehr MV, Siber GR, Welliver RC. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr. 1996 Aug; 129(2):214-9. PMID: 8765618.
      Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
    63. Kimpen JL, Garofalo R, Welliver RC, Fujihara K, Ogra PL. An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus. Pediatr Allergy Immunol. 1996 Feb; 7(1):48-53. PMID: 8792384.
      Citations: 9     Fields:    Translation:HumansCells
    64. Welliver RC. RSV and chronic asthma. Lancet. 1995 Sep 23; 346(8978):789-90. PMID: 7674741.
      Citations: 13     Fields:    Translation:Humans
    65. Piedra PA, Glezen WP, Kasel JA, Welliver RC, Jewel AM, Rayford Y, Hogerman DA, Hildreth SW, Paradiso PR. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine. 1995 Aug; 13(12):1095-101. PMID: 7491817.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    66. Groothuis JR, Simoes EA, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ, Arrobio J, Welliver RC, Siber GR. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin. Antimicrob Agents Chemother. 1995 Mar; 39(3):668-71. PMID: 7793870.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    67. Welliver RC, Tristram DA, Batt K, Sun M, Hogerman D, Hildreth S. Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine. J Infect Dis. 1994 Aug; 170(2):425-8. PMID: 8035030.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    68. Rodriguez WJ, Hall CB, Welliver R, Simoes EA, Ryan ME, Stutman H, Johnson G, Van Dyke R, Groothuis JR, Arrobio J, et al. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. J Pediatr. 1994 Jul; 125(1):129-35. PMID: 8021762.
      Citations: 18     Fields:    Translation:HumansCellsCTClinical Trials
    69. Tristram DA, Welliver RC, Hogerman DA, Hildreth SW, Paradiso P. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. Vaccine. 1994 May; 12(6):551-6. PMID: 8036830.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    70. Tristram DA, Welliver RC. Respiratory syncytial virus vaccines: can we improve on nature? Pediatr Ann. 1993 Dec; 22(12):715-8. PMID: 8139872.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    71. Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18; 329(21):1524-30. PMID: 8413475.
      Citations: 197     Fields:    Translation:HumansCellsCTClinical Trials
    72. Tristram DA, Welliver RC, Mohar CK, Hogerman DA, Hildreth SW, Paradiso P. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J Infect Dis. 1993 Jan; 167(1):191-5. PMID: 8418166.
      Citations: 28     Fields:    Translation:HumansCellsCTClinical Trials
    73. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol. 1993 Jan; 15(1):19-27. PMID: 8419894.
      Citations: 37     Fields:    Translation:HumansCells
    74. Kimpen JL, Garofalo R, Welliver RC, Ogra PL. Activation of human eosinophils in vitro by respiratory syncytial virus. Pediatr Res. 1992 Aug; 32(2):160-4. PMID: 1324464.
      Citations: 19     Fields:    Translation:HumansCells
    75. Garofalo R, Kimpen JL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr. 1992 Jan; 120(1):28-32. PMID: 1731020.
      Citations: 65     Fields:    Translation:HumansCells
    76. Welliver RC. The role of antihistamines in upper respiratory tract infections. J Allergy Clin Immunol. 1990 Oct; 86(4 Pt 2):633-6; discussion 636-7. PMID: 2229825.
      Citations:    Fields:    Translation:HumansCells
    77. Chandwani S, Borkowsky W, Krasinski K, Lawrence R, Welliver R. Respiratory syncytial virus infection in human immunodeficiency virus-infected children. J Pediatr. 1990 Aug; 117(2 Pt 1):251-4. PMID: 2380825.
      Citations: 15     Fields:    Translation:HumansCells
    78. Welliver RC, Sun M, Hildreth SW, Arumugham R, Ogra PL. Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection. J Clin Microbiol. 1989 Feb; 27(2):295-9. PMID: 2915022.
      Citations: 12     Fields:    Translation:HumansCells
    79. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res. 1988 Oct; 24(4):504-7. PMID: 3174295.
      Citations: 35     Fields:    Translation:HumansCells
    80. Welliver RC. Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev. 1988 Jan; 1(1):27-39. PMID: 3060243.
      Citations: 21     Fields:    Translation:HumansCells
    81. Rosner IK, Welliver RC, Edelson PJ, Geraci-Ciardullo K, Sun M. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection. J Infect Dis. 1987 May; 155(5):1043-7. PMID: 3559277.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    82. Welliver RC, Ogra PL. Respiratory syncytial virus-specific IgE antibody responses at the mucosal surface: predictive value for recurrent wheezing and suppression by ribavirin therapy. Adv Exp Med Biol. 1987; 216B:1701-8. PMID: 3425457.
      Citations:    Fields:    Translation:HumansCells
    83. Welliver RC, Sun M, Rinaldo D, Ogra PL. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr. 1986 Nov; 109(5):776-80. PMID: 3772657.
      Citations: 39     Fields:    Translation:HumansCells
    84. Welliver RC, Sun M, Rinaldo D, Ogra PL. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response. Pediatr Res. 1985 May; 19(5):420-4. PMID: 4000767.
      Citations: 9     Fields:    Translation:HumansCells
    85. Kaul TN, Welliver RC, Faden HS, Ogra PL. The development of respiratory syncytial virus-specific immune complexes in nasopharyngeal secretions following natural infection. J Clin Lab Immunol. 1984 Dec; 15(4):187-90. PMID: 6527374.
      Citations: 3     Fields:    Translation:HumansCells
    86. Ogra PL, Welliver RC, Riepenhoff-Talty M, Faden HS. Interaction of mucosal immune system and infections in infancy: implications in allergy. Ann Allergy. 1984 Dec; 53(6 Pt 2):523-34. PMID: 6239576.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    87. Welliver RC, Kaul TN, Sun M, Ogra PL. Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol. 1984 Oct; 133(4):1925-30. PMID: 6236259.
      Citations: 23     Fields:    Translation:HumansCells
    88. Welliver RC. Upper respiratory infections in asthma. J Allergy Clin Immunol. 1983 Oct; 72(4):341-6. PMID: 6352778.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    89. Welliver RC, Ogra PL. Use of immunofluorescence in the study of the pathogenesis of respiratory syncytial virus infection. Ann N Y Acad Sci. 1983; 420:369-75. PMID: 6372603.
      Citations:    Fields:    Translation:HumansCells
    90. Welliver RC, Wong DT, Middleton E, Sun M, McCarthy N, Ogra PL. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr. 1982 Dec; 101(6):889-96. PMID: 6183418.
      Citations: 21     Fields:    Translation:HumansCells
    91. Kaul TN, Welliver RC, Ogra PL. Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus. Infect Immun. 1982 Aug; 37(2):492-8. PMID: 7118247.
      Citations: 10     Fields:    Translation:HumansCells
    92. Kaul TN, Welliver RC, Ogra PL. Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus. J Med Virol. 1982; 9(2):149-58. PMID: 7069409.
      Citations: 13     Fields:    Translation:HumansCells
    93. Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL. Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child. 1981 Nov; 135(11):1013-6. PMID: 7294005.
      Citations: 20     Fields:    Translation:HumansCells
    94. Welliver RC, Wong DT, Sun M, Middleton E, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981 Oct 08; 305(15):841-6. PMID: 6168908.
      Citations: 111     Fields:    Translation:HumansCells
    95. Welliver RC, Ogra PL. Respiratory syncytial virus. Compr Ther. 1981 Jun; 7(6):34-40. PMID: 7249574.
      Citations:    Fields:    Translation:HumansCells
    96. Kaul TN, Welliver RC, Ogra PL. Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus. J Clin Microbiol. 1981 May; 13(5):957-62. PMID: 7016915.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    97. Welliver RC, Gallagher MR, Ogra PL. Clinical and laboratory diagnosis of respiratory syncytial virus infection. Crit Rev Clin Lab Sci. 1981; 13(3):213-39. PMID: 7018832.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    98. Welliver RC, Kaul TN, Ogra PL. The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med. 1980 Nov 20; 303(21):1198-202. PMID: 7421946.
      Citations: 32     Fields:    Translation:HumansCells
    99. Welliver RC, Kaul TN, Putnam TI, Sun M, Riddlesberger K, Ogra PL. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr. 1980 May; 96(5):808-13. PMID: 7365579.
      Citations: 45     Fields:    Translation:HumansCells
    100. Welliver RC, Kaul A, Ogra PL. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr. 1979 Mar; 94(3):370-5. PMID: 423016.
      Citations: 30     Fields:    Translation:HumansCells
    Welliver's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (345)
    Co-Authors (15)
    Similar People (56)
    Same Department Expand Description
    Physical Neighbors